Tag: yellow fever vaccine market

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

#Yellow Fever Vaccine Market Size And Revenue Outlook Through 2030#_x000D_

The yellow fever vaccine market size has experienced consistent expansion in recent years. It is projected to increase from $4.74 billion in 2025 to $4.97 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.8%. Historically, this growth was driven by recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives._x000D_

_x000D_

The yellow fever vaccine market size is anticipated to show consistent expansion in the upcoming years, projected to reach $5.88 billion in 2030, achieving a compound annual growth rate (CAGR) of 4.3%. This growth during the forecast period is influenced by factors such as the climate-driven spread of mosquitoes, a rise in global travel, the broadening of vaccination infrastructure, increased funding for disease prevention, and enhanced outbreak preparedness. Key developments for the period encompass the expansion of routine immunization programs, an increased demand from international travelers, more government-led vaccination campaigns, the growing adoption of single-dose vaccines, and a focus on preventing endemic diseases._x000D_

_x000D_

#Get A Free Sample Report With In-Depth Market Insights:#_x000D_

https://thebusinessresearchcompany.com/sample_request?id=14706566&type=smp&name=Yellow%20Fever%20Vaccine%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Yellow Fever Vaccine Market Demand Drivers: What’s Powering Industry Growth?#_x000D_

The future expansion of the yellow fever vaccine market is anticipated, driven by the increasing international travel. This international travel refers to the movement of individuals across country borders for tourism, business, or personal purposes. The rise in international travel is attributed to growing global mobility, bolstered by economic recovery and the easing of post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by providing mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, up from 0.96 billion in 2022, marking an increase of 0.326 billion international tourists year-on-year. Therefore, the expansion of international travel is driving the growth of the yellow fever vaccine market._x000D_

_x000D_

#Yellow Fever Vaccine Market Segment Outlook: Which Categories Are Growing Fastest?#_x000D_

The yellow fever vaccine market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Powder, Liquid _x000D_

2) By Application: Routine Immunization, Travelers, Other Applications_x000D_

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution _x000D_

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes_x000D_

_x000D_

#Yellow Fever Vaccine Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_

Companies leading the yellow fever vaccine market are increasingly dedicated to developing innovative solutions, such as T-cell adaptive booster vaccines. This focus aims to enhance long-term immunity, improve the effectiveness of vaccines, and overcome the limitations of conventional live-attenuated vaccines. T-cell adaptive booster vaccines are specifically designed to fortify the immune system by boosting T-cell responses, which enables the body to identify and combat infections more efficiently compared to traditional antibody-centric vaccines. For example, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, introduced Yellow Fever Vaccination to offer travelers protection against the mosquito-borne viral disease and to issue the internationally recognized vaccination certificate. This initiative seeks to improve vaccine accessibility within Telangana, thereby reducing the need for extensive travel to other authorized centers. Additionally, the program upholds international health regulations by ensuring safe administration under medical supervision, particularly for individuals with contraindications._x000D_

_x000D_

#Yellow Fever Vaccine Market Leading Companies And Competitive Benchmarking#_x000D_

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated _x000D_

_x000D_

#View The Full Yellow Fever Vaccine Market Report:#_x000D_

https://thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR_x000D_

_x000D_

#Yellow Fever Vaccine Market Largest Region: Which Geography Holds The Biggest Share?#_x000D_

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Reach Out To Our Team:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas: +1 310-496-7795_x000D_

Asia: +44 7882 955267 & +91 8897263534_x000D_

Europe: +44 7882 955267_x000D_

Email us at: marketing@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Yellow Fever Vaccine Market Size Outlook: How Fast Will Revenue Grow Through 2030?

The market for yellow fever vaccines has experienced consistent expansion over the past few years. Projections indicate an increase from $4.74 billion in 2025 to $4.97 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.8%. This historical growth has been driven by factors such as repeated yellow fever outbreaks, compulsory government vaccination policies, proven vaccine effectiveness, travel regulations imposed by international authorities, and various public health programs.

The yellow fever vaccine market is projected to experience consistent expansion over the coming years, reaching an estimated value of $5.88 billion by 2030, with a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast period is driven by factors such as the climate-induced spread of mosquitoes, a rise in international travel, improvements in vaccination infrastructure, increased financial support for disease prevention initiatives, and enhanced readiness for outbreaks. Key trends shaping this period include the broadening of routine immunization programs, heightened demand from global travelers, more frequent government-led vaccination drives, a shift toward single-dose vaccine options, and a concentrated effort on preventing diseases in endemic regions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Yellow Fever Vaccine Market Expansion Drivers: What Is Shaping Future Growth?

The growth of the yellow fever vaccine market is anticipated to be driven by a rise in international travel moving forward. This type of travel involves people crossing national borders for activities like tourism, business, or personal reasons. An increase in international travel is being seen due to heightened global mobility, supported by economic recovery and the relaxation of pandemic-related restrictions. By offering necessary or suggested immunizations for entry into areas where yellow fever is present, the vaccine market serves the needs of travelers. As an example, data from the World Tourism Organization (UNWTO) in January 2024 reveals that global international tourist arrivals hit 1.286 billion in 2023, compared to 0.96 billion in 2022, marking a year-on-year rise of 0.326 billion tourists. Consequently, the expansion of the yellow fever vaccine market is fueled by growing international travel.

Yellow Fever Vaccine Market Segmentation And Category Breakdown

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Yellow Fever Vaccine Market Strategic Trends: What Is Defining The Next Phase Of Growth?

Major players in the yellow fever vaccine industry are placing greater emphasis on creating novel solutions, including T-cell adaptive booster vaccines, to strengthen long-lasting immunity, boost vaccine effectiveness, and overcome the drawbacks of conventional live-attenuated vaccines. These T-cell adaptive booster vaccines are formulated to reinforce the immune system by particularly augmenting T-cell responses, enabling the body to detect and combat infections more efficiently than standard antibody-centric vaccines. As an example, in April 2025, the All India Institute of Medical Sciences, a healthcare facility based in India, introduced the Yellow Fever Vaccination service to shield travelers from the mosquito-transmitted viral disease and provide the globally recognized vaccination certificate. This effort is designed to improve vaccine availability within Telangana, thereby minimizing the necessity for extended travel to other permitted centers. Moreover, the program complies with international health standards by guaranteeing safe vaccine delivery under medical oversight, especially for those with medical contraindications.

Yellow Fever Vaccine Market Competitive Analysis Of Major Industry Participants

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Access The Complete Yellow Fever Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Yellow Fever Vaccine Market Largest Region By Revenue And Market Share

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

How Will The Market Size Of The Yellow Fever Vaccine Market Progress Through 2030?

The yellow fever vaccine market has experienced consistent growth in recent times. It will grow from $4.74 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this historical growth include repeated yellow fever outbreaks, government-mandated immunization programs, established vaccine effectiveness, international travel regulations, and various public health initiatives.

The yellow fever vaccine market is projected to observe consistent expansion over the coming years. Its valuation is forecast to reach $5.88 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. The drivers behind this growth within the forecast timeframe include the climate-induced spread of mosquitoes, an uptick in global travel, the enhancement of vaccination infrastructure, increased funding allocated to disease prevention, and strengthened preparedness for outbreaks. Significant trends anticipated during this period encompass the broadening of routine immunization initiatives, escalating demand from international travelers, more extensive government-led vaccination campaigns, the increasing adoption of single-dose vaccines, and a concentrated effort on preventing endemic diseases.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Primary Factors Are Fueling The Expansion Of The Yellow Fever Vaccine Market?

The yellow fever vaccine market is projected to expand as a result of the rising volume of international travel. This travel involves individuals crossing national boundaries for tourism, business, or personal reasons. Global mobility is increasing, driving this surge in international travel, which is further aided by economic improvements and the relaxation of post-pandemic travel limitations. The yellow fever vaccine market caters to travelers by offering essential or suggested immunizations required for entry into areas where the disease is prevalent. As an illustration, figures from January 2024, released by the World Tourism Organization (UNWTO), an international tourism agency located in Spain, indicated that worldwide international tourist arrivals totaled 1.286 billion in 2023. This marks an increase from 0.96 billion in 2022, signifying a year-on-year rise of 0.326 billion international tourists. Consequently, the expansion of international travel is a key factor propelling the yellow fever vaccine market’s growth.

Which Segment Divisions Form The Structure Of The Yellow Fever Vaccine Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Trends Are Shaping The Yellow Fever Vaccine Market Structure?

Leading companies in the yellow fever vaccine market are increasingly directing their efforts toward developing innovative solutions, such as T-cell adaptive booster vaccines, with the goal of enhancing long-term immunity, improving vaccine efficacy, and addressing the limitations inherent in traditional live-attenuated vaccines. T-cell adaptive booster vaccines are designed to bolster the immune system through the specific amplification of T-cell responses, which enables the body to recognize and fight infections more effectively compared to conventional antibody-focused vaccines. For example, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, introduced Yellow Fever Vaccination services. These services aim to provide travelers with protection against the mosquito-borne viral disease and to issue the globally recognized vaccination certificate. The initiative is intended to increase the accessibility of the vaccine within Telangana, thereby reducing the need for individuals to travel long distances to other authorized centers. Additionally, the program ensures strict adherence to international health regulations by providing safe administration under medical supervision, particularly for individuals who have contraindications.

Who Are The Leading Firms Participating In The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Access The Complete Yellow Fever Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

What Is The Largest Regional Market In The Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Yellow Fever Vaccine Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Estimated Market Size Of The Yellow Fever Vaccine Market In 2026, And How Will Its Value Evolve By 2030?

The yellow fever vaccine market size has shown consistent expansion in recent years. It is projected to increase from $4.74 billion in 2025 to $4.97 billion in 2026, advancing at a compound annual growth rate (CAGR) of 4.8%. The growth observed in the preceding period can be linked to recurrent yellow fever outbreaks, government-issued immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives.

The yellow fever vaccine market size is anticipated to experience consistent expansion over the coming years. This market is projected to reach $5.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. The expansion during this forecast period stems from factors such as climate-driven mosquito propagation, an increase in global travel, the broadening of vaccination infrastructure, enhanced funding for disease prevention, and improved outbreak readiness. Prominent trends expected within the forecast timeframe encompass the expansion of routine immunization initiatives, an escalating demand from international travelers, a rise in government-led vaccination drives, the increasing adoption of single-dose vaccines, and a concentrated effort on preventing endemic diseases.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Key Drivers Are Affecting The Yellow Fever Vaccine Market Development?

The yellow fever vaccine market is anticipated to expand, propelled by the rise in international travel. International travel involves individuals journeying across national borders for tourism, business, or personal reasons. This increase in international travel is driven by growing global mobility, bolstered by economic recovery and the relaxation of post-pandemic travel restrictions. The yellow fever vaccine market supports travelers by offering mandatory or recommended immunization for entry into regions where yellow fever is endemic. For instance, in January 2024, according to the World Tourism Organization (UNWTO), a Spain-based international tourism agency, global international tourist arrivals reached 1.286 billion in 2023, marking an increase from 0.96 billion in 2022, which represents a rise of 0.326 billion international tourists year-on-year. Consequently, increasing international travel is a primary driver for the growth of the yellow fever vaccine market.

How Are Different Segments Classified In The Yellow Fever Vaccine Market Segment Analysis?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Trends Are Transforming The Yellow Fever Vaccine Market?

Major companies in the yellow fever vaccine market are increasingly directing their efforts towards developing innovative solutions, such as T-cell adaptive booster vaccines, to strengthen long-term immunity, boost vaccine efficacy, and overcome the shortcomings of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are formulated to fortify the immune system by specifically enhancing T-cell responses, which enable the body to detect and combat infections more effectively compared to conventional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare provider, launched Yellow Fever Vaccination services to offer travelers protection against the mosquito-borne viral disease and to issue the internationally recognized vaccination certificate. This program aims to expand access to the vaccine within Telangana, thereby reducing the requirement for lengthy journeys to other authorized centers. Moreover, the initiative ensures adherence to international health regulations by providing safe administration under medical supervision, particularly for those with contraindications.

Who Are The Companies Driving Activity In The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Get The Full Yellow Fever Vaccine Market Report:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Region Has The Greatest Market Share In The Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Yellow Fever Vaccine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Yellow Fever Vaccine Market Across 2026–2030?

The yellow fever vaccine market has demonstrated consistent growth in recent years. It is anticipated to increase from $4.74 billion in 2025 to $4.97 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.8%. Factors contributing to this historical growth include recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and public health initiatives.

The yellow fever vaccine market is projected to experience consistent expansion in the coming years, with its size anticipated to reach $5.88 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. This growth during the forecast period is attributable to factors such as climate-driven mosquito spread, increasing global travel, the expansion of vaccination infrastructure, higher funding allocated for disease prevention, and stronger outbreak preparedness. Significant trends expected in the forecast period include the broadening of routine immunization programs, a rising demand from international travelers, an increase in government-led vaccination campaigns, the growing use of single-dose vaccines, and an intensified focus on endemic disease prevention.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Market Drivers Are Supporting The Expansion Of The Yellow Fever Vaccine Market?

The steady rise in international travel is anticipated to stimulate the future growth of the yellow fever vaccine market. International travel denotes the passage of individuals across national boundaries for recreational, commercial, or private objectives. This increase in international travel stems from heightened global movement, which is further bolstered by global economic recovery and the relaxation of post-pandemic travel restrictions. The yellow fever vaccine market assists travelers by offering either mandatory or suggested immunizations for access to areas where yellow fever is prevalent. For example, in January 2024, the World Tourism Organization (UNWTO), an international tourism agency located in Spain, reported that global international tourist arrivals reached 1.286 billion in 2023, an increase from 0.96 billion in 2022, marking a year-on-year rise of 0.326 billion international tourists. Consequently, the expansion of international travel is a key factor propelling the growth of the yellow fever vaccine market.

What Segmentation Levels Are Considered In The Yellow Fever Vaccine Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Trends Are Projected To Affect The Yellow Fever Vaccine Market?

Leading companies within the yellow fever vaccine market are progressively concentrating on creating novel solutions, including T-cell adaptive booster vaccines. This effort aims to boost long-lasting immunity, enhance vaccine effectiveness, and overcome the drawbacks associated with conventional live-attenuated vaccines. T-cell adaptive booster vaccines are formulated to bolster the immune system by specifically amplifying T-cell responses. These responses enable the body to identify and combat infections with greater efficiency than older, antibody-centric vaccines. As an illustration, in April 2025, the All India Institute of Medical Sciences, a healthcare institution located in India, initiated Yellow Fever Vaccination services. This service offers travelers defense against the mosquito-borne viral illness and provides the globally recognized vaccination certificate. The objective of this program is to broaden access to the vaccine within Telangana, thereby lessening the necessity for individuals to travel extensively to alternative authorized facilities. Furthermore, the program guarantees compliance with international health regulations through its provision of safe administration under professional medical oversight, especially benefiting those with specific medical contraindications.

Which Leading Firms Are Contributing To The Growth Of The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Read the full yellow fever vaccine market report here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

How Is The Yellow Fever Vaccine Market Distributed Across Key Geographic Regions?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Yellow Fever Vaccine Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the yellow fever vaccine market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Yellow Fever Vaccine Market between 2026 and 2030?

The yellow fever vaccine market size has consistently expanded in recent years. This market is anticipated to increase from $4.74 billion in 2025 to $4.97 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.8%. Historically, the growth witnessed in this sector has been largely due to recurring yellow fever outbreaks, government immunization mandates, established vaccine efficacy, international travel requirements, and various public health initiatives.

The yellow fever vaccine market is projected to experience consistent expansion over the upcoming years. By 2030, its valuation is anticipated to reach $5.88 billion, demonstrating a compound annual growth rate (CAGR) of 4.3%. This forecasted growth is primarily driven by factors such as climate-driven mosquito dispersion, a rise in international travel, the broadening of vaccination infrastructure, increased financial investment in disease prevention, and enhanced outbreak preparedness measures. Key trends expected during this period encompass the enlargement of routine immunization initiatives, a growing need from travelers crossing borders, more extensive government-sponsored vaccination drives, an increasing preference for single-dose vaccines, and a concentrated effort on preventing endemic diseases.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Drivers Are Expected To Impact The Yellow Fever Vaccine Market During The Forecast Period?

The yellow fever vaccine market is anticipated to grow as international travel increases. This refers to the movement of individuals across national borders for purposes such as tourism, business, or personal visits. The rise in international travel is being driven by increasing global mobility, supported by economic recovery and the easing of post-pandemic travel restrictions. The yellow fever vaccine market caters to travelers by providing essential or recommended immunizations required for entry into regions where yellow fever is widespread. For instance, in January 2024, the World Tourism Organization (UNWTO), an international tourism agency based in Spain, reported that global international tourist arrivals reached 1.286 billion in 2023. This figure is significantly higher than the 0.96 billion recorded in 2022, marking an increase of 0.326 billion international tourists year-on-year. Therefore, the growth of the yellow fever vaccine market is being propelled by the surge in international travel.

Which Segments Are Driving Activity In The Yellow Fever Vaccine Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Application: Routine Immunization, Travelers, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Trends Are Shaping Activity Within The Yellow Fever Vaccine Market?

Leading companies in the yellow fever vaccine market are increasingly focusing on developing innovative solutions, such as T-cell adaptive booster vaccines, to enhance long-term immunity, improve vaccine efficacy, and address the limitations of traditional live-attenuated vaccines. T-cell adaptive booster vaccines are designed to strengthen the immune system by specifically enhancing T-cell responses, which help the body recognize and fight infections more effectively compared to traditional antibody-focused vaccines. For instance, in April 2025, the All India Institute of Medical Sciences, an India-based healthcare institute, launched Yellow Fever Vaccination to provide travelers with protection against the mosquito-borne viral disease and issue the internationally recognized vaccination certificate. This initiative aims to increase accessibility to the vaccine within Telangana, reducing the need for long-distance travel to other authorized centers. Additionally, the program ensures adherence to international health regulations by offering safe administration under medical supervision, particularly for individuals with contraindications.

Which Key Players Are Driving Competition In The Yellow Fever Vaccine Market?

Major companies operating in the yellow fever vaccine market are Sanofi S.A., Bio-Manguinhos, Institut Pasteur de Dakar, Instituto Butantan, Bio Farma, Biological E. Limited, Beijing Tiantan Biological Products Co. Ltd., Wuhan Institute of Biological Products, Merck & Co. Inc., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Lonza Group AG, WuXi Biologics, Ology Bioservices, Valneva SE, Bavarian Nordic A/S, Panacea Biotec Ltd., Biovac, Novavax Inc., PnuVax Incorporated

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Region Is Projected To Lead The Yellow Fever Vaccine Market During The Forecast Period?

North America was the largest region in the yellow fever vaccine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Yellow Fever Vaccine Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Browse Through More Reports Similar to the Global Yellow Fever Vaccine Market 2026, By The Business Research Company

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Yellow Fever Vaccine Market Report 2026

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Vaccines Market Report 2026

https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the gummy vitamins market from 2025–2034 with trusted insights from The Business Research Company

What CAGR And Valuation Are Anticipated For The Gummy Vitamins Market By The End Of 2029?

The yellow fever vaccine market size has experienced consistent growth in recent years. It is projected to expand from $4.54 billion in 2024 to $4.74 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.4%. This historical growth can be attributed to several factors including the launch of global immunization campaigns, the implementation of international health regulations, widespread vaccination initiatives, and advancements in vaccine production technology.

The yellow fever vaccine market size is anticipated to demonstrate consistent expansion in the coming years. It is projected to achieve a value of $5.66 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.5%. This market’s development over the forecast period stems from heightened collaboration and partnerships, its integration into routine vaccination schedules, effective surveillance and monitoring, increased private sector involvement, and the adoption of digital technologies for vaccine tracking. Significant trends identified for this period include the diversification of vaccine formats, initiatives for pandemic preparedness, evolving regulatory frameworks, improvements in healthcare infrastructure, and enhanced consumer education and awareness.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

Which Business Drivers Are Underpinning The Growth Of The Gummy Vitamins Market?

The yellow fever vaccine market is projected to expand in the future due to a rise in international travel. This type of travel involves people crossing national boundaries for activities like sightseeing, business engagements, or personal visits. The surge in global connectivity, robust economic expansion, and the easing of pandemic-related travel curbs are contributing to this increase in international journeys. Travelers heading to areas where yellow fever is prevalent need or are advised to receive the vaccine to avert infection and adhere to global health protocols. As an illustration, data from the Spain-based World Tourism Organization in January 2024 revealed that the global count of international tourists (overnight visitors) reached 1.286 billion in 2023, up from 960 million in 2022. This indicates a year-over-year increment of 326 million international tourists between 2022 and 2023. Consequently, the expanding volume of international travel is fueling the expansion of the yellow fever vaccine market.

What Are The Principal Segment Types In The Gummy Vitamins Market?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

How Are Industry Trends Steering The Expansion Of The Gummy Vitamins Market?

Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. This type of vaccine is designed to enhance the immune system’s memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.

Which Companies Are Contributing Significantly To The Gummy Vitamins Market Growth?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Region Offers The Most Opportunity For Gummy Vitamins Market Expansion?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

Browse Through More Reports Similar to the Global Gummy Vitamins Market 2025, By The Business Research Company

Adult Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Porcine Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report

Therapeutic Bcg Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Yellow Fever Vaccine Market?

Over the past few years, the market size for the yellow fever vaccine has shown consistent growth. The market is expected to expand from $4.54 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. This growth during the historic period is credited to the launch of worldwide immunization initiatives, enactment of international health laws, large-scale vaccination drives, and progress in vaccine production technology.

Anticipations are set for a consistent expansion of the yellow fever vaccine market in the coming years. The market is projected to swell up to “$5.66 billion by the year 2029, achieving a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the projection period include enhanced collaborations and partnerships, incorporation in standard immunization timelines, advanced surveillance and vigilance, rising participation of private sectors, and the embracement of digital innovation for vaccine monitoring. Prominent trends for this period count on the diversification of vaccine molds, preparedness for pandemics, modifications in regulations, advancements in healthcare infrastructure, and initiatives towards consumer education and consciousness.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Core Drivers Are Expected To Influence The Yellow Fever Vaccine Market?

The surge in global travel is predicted to drive the expansion of the yellow fever vaccine market. Global travel entails the cross-border movement of people for reasons such as tourism, work, or personal matters. An upswing in global connectivity, economic advancement, and the easing of travel restrictions in the post-pandemic era are fueling the rise in international travel. The yellow fever vaccine is either mandatory or advised for individuals traveling to areas where yellow fever is prevalent to prevent contraction of the disease and adhere to global health rules. For example, data from the World Tourism Organization, a Spanish agency, shows that in 2023, there were 1.286 billion global tourists (those staying overnight), compared to 960 million in 2022. This represents a boost of 326 million international tourists between 2022 and 2023. Consequently, the increased volume of international travel is stimulating the expansion of the yellow fever vaccine market.

What Segmentation Insights Are Provided In The Yellow Fever Vaccine Market Research?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Notable Trends Are Transforming The Yellow Fever Vaccine Market Outlook?

Key players in the yellow fever vaccine market are channeling their efforts towards the development of efficient next-generation vaccines for yellow fever, like the T-cell adaptive booster vaccine, in response to the rising worldwide demand for vaccines. These booster vaccines are designed to amplify the immune system’s recollection of T-cells, thereby offering extended and strong immunity to certain pathogens. To cite an example, in April 2022, Emergex Vaccines Holding Limited, a biotechnology firm based in the UK, collaborated with the US-based non-profit organization, ATCC, which offers reference microorganisms, cell lines, and other materials for research and development. Together, they are developing CD8+ T-cell adaptive vaccines for yellow fever. The goal is to trigger a strong cytotoxic T-cell response, necessary for the detection and destruction of virus-infected cells. By encouraging the generation of memory CD8+ T-cells, these vaccines offer enduring and robust immunity. Instead of limiting their focus to antibody production, these vaccines aim at engaging the cellular immune response, promising comprehensive protection against yellow fever and potentially boosting effectiveness among individuals with varying immunity profiles.

Which Companies Are Contributing Significantly To The Yellow Fever Vaccine Market Growth?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim 30% Off Global Market Reports With Code ONLINE30 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

What Is The Present And Forecasted Size Of The Yellow Fever Vaccine Market?

Over the past few years, the market size for the yellow fever vaccine has shown consistent growth. The market is expected to expand from $4.54 billion in 2024 to $4.74 billion in 2025, with a compound annual growth rate (CAGR) of 4.4%. This growth during the historic period is credited to the launch of worldwide immunization initiatives, enactment of international health laws, large-scale vaccination drives, and progress in vaccine production technology.

Anticipations are set for a consistent expansion of the yellow fever vaccine market in the coming years. The market is projected to swell up to “$5.66 billion by the year 2029, achieving a compound annual growth rate (CAGR) of 4.5%. Factors contributing to this growth during the projection period include enhanced collaborations and partnerships, incorporation in standard immunization timelines, advanced surveillance and vigilance, rising participation of private sectors, and the embracement of digital innovation for vaccine monitoring. Prominent trends for this period count on the diversification of vaccine molds, preparedness for pandemics, modifications in regulations, advancements in healthcare infrastructure, and initiatives towards consumer education and consciousness.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Core Drivers Are Expected To Influence The Yellow Fever Vaccine Market?

The surge in global travel is predicted to drive the expansion of the yellow fever vaccine market. Global travel entails the cross-border movement of people for reasons such as tourism, work, or personal matters. An upswing in global connectivity, economic advancement, and the easing of travel restrictions in the post-pandemic era are fueling the rise in international travel. The yellow fever vaccine is either mandatory or advised for individuals traveling to areas where yellow fever is prevalent to prevent contraction of the disease and adhere to global health rules. For example, data from the World Tourism Organization, a Spanish agency, shows that in 2023, there were 1.286 billion global tourists (those staying overnight), compared to 960 million in 2022. This represents a boost of 326 million international tourists between 2022 and 2023. Consequently, the increased volume of international travel is stimulating the expansion of the yellow fever vaccine market.

What Segmentation Insights Are Provided In The Yellow Fever Vaccine Market Research?

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Notable Trends Are Transforming The Yellow Fever Vaccine Market Outlook?

Key players in the yellow fever vaccine market are channeling their efforts towards the development of efficient next-generation vaccines for yellow fever, like the T-cell adaptive booster vaccine, in response to the rising worldwide demand for vaccines. These booster vaccines are designed to amplify the immune system’s recollection of T-cells, thereby offering extended and strong immunity to certain pathogens. To cite an example, in April 2022, Emergex Vaccines Holding Limited, a biotechnology firm based in the UK, collaborated with the US-based non-profit organization, ATCC, which offers reference microorganisms, cell lines, and other materials for research and development. Together, they are developing CD8+ T-cell adaptive vaccines for yellow fever. The goal is to trigger a strong cytotoxic T-cell response, necessary for the detection and destruction of virus-infected cells. By encouraging the generation of memory CD8+ T-cells, these vaccines offer enduring and robust immunity. Instead of limiting their focus to antibody production, these vaccines aim at engaging the cellular immune response, promising comprehensive protection against yellow fever and potentially boosting effectiveness among individuals with varying immunity profiles.

Which Companies Are Contributing Significantly To The Yellow Fever Vaccine Market Growth?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Yellow Fever Vaccine Market?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the Gummy Vitamins Market Expected to Be in 2029?

Over the past few years, the yellow fever vaccine market has demonstrated consistent growth. It is projected to expand from $4.54 billion in 2024 to $4.74 billion in 2025, marking a compound annual growth rate (CAGR) of 4.4%. The previous growth period’s escalation can be credited to the launching of worldwide immunization drives, the establishment of international health rules, mass immunization initiatives, and progress in vaccine manufacturing technology.

In the coming years, the yellow fever vaccine market size is forecasted to exhibit consistent growth. It is predicted to expand to “$5.66 billion in 2029, experiencing a compound annual growth rate (CAGR) of 4.5%. The foreseeable growth can be credited to factors such as heightened collaboration and partnerships, routine vaccination schedule integration, expansive surveillance and monitoring, increased participation from the private sector, and the implementation of digital technologies for vaccine traceability. Significant trends for the projected period encompass the diversification of vaccine formats, readiness for pandemics, regulatory alterations, enhancements in healthcare infrastructure, and the promotion of consumer education and awareness.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17297&type=smp

What Are The Contributors To Demand In The Gummy Vitamins Market?

The gummy vitamins market is expected to expand due to the growing number of vegans. A vegan, who adopts a lifestyle free from any animal products consumption and in many instances, also evades utilization of other products derived from animals, represents a potential market opportunity for gummy vitamin producers. Specifically, these manufacturers can align their product offerings with an expanding customer segment’s philosophies and choices. For example, the Plant Based Foods Association in the U.S. reported a 6.6% growth in sales of plant-based foods in 2022, a progression from the 5.9% increase noted in 2021. Hence, the rise in the vegan population is likely to foster the demand and growth of the gummy vitamins market.

The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid

2) By Treatment Type: Pain Management Drugs, Oral Rehydration

3) By Application: Routine Immunization, Travelers, Other Applications

4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:

1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution

2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

Which Trends Are Redefining The Future Landscape Of The Gummy Vitamins Industry?

Major players in the yellow fever vaccine market are pivoting towards creating next-generation yellow fever vaccines, including the T-cell adaptive booster vaccine, to cater to the growing demand for vaccines worldwide. The T-cell adaptive booster vaccine is designed to augment the reaction of the immune system’s memory T-cells, resulting in durable and potent resistance to certain pathogens. Emergex Vaccines Holding Limited, a biotech firm based in the UK, teamed up with ATCC, a non-profit organization based in America that supplies reference microorganisms, cell lines, and other research and development resources, in April 2022 to launch CD8+ T-cell adaptive vaccines. These vaccines, designed specifically for yellow fever, aim to trigger a powerful cytotoxic T-cell response vital for locating and destroying virus-infected cells. By increasing the generation of memory CD8+ T-cells, these vaccines deliver enduring and robust immunity. They target the cellular immune response instead of solely prioritising antibody creation, thus providing thorough protection against yellow fever and potentially improving efficiency in individuals with varying immune profiles.

Who Are The Top-Ranked Companies In The Gummy Vitamins Market Today?

Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

https://www.thebusinessresearchcompany.com/report/yellow-fever-vaccine-global-market-report

How Is Gummy Vitamins Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=17297&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model